Health Care • Medical/Dental Instruments
$119.65 ▼ -0.14
(-0.12%)
MKT CAP: $5.44B • VOL: 453.4K
52W L $50 52W H $124
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$101
MEDIAN
$134
MEAN
$136
HIGH
$163
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HAE TAPE
HAE // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $144.78 | $137.60 | 2025-02-14 | $108.88 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $150.76 | $141.19 | 2025-02-06 | $112.47 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $136.40 | $131.62 | 2025-01-29 | $114.86 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $122.04 | — | 2025-01-17 | $117.26 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $105.29 | $113.67 | 2025-01-09 | $106.49 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $142.38 | $124.44 | 2024-12-18 | $104.10 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $116.06 | $120.85 | 2024-12-04 | $111.27 | -4.3% | 48% | C |